Direct-to-patient virtual care is the future of pharma

With 180 million Americans using telehealth, the question isn’t whether they prefer virtual care, but whether your brand is part of their journey. Life sciences invests billions in commercialization yet remains focused on traditional engagement strategies, missing key patient interactions outside their network. Move beyond awareness and build real relationships.

Is telehealth part of your commercialization strategy?

Patients are choosing virtual care faster than ever, making telehealth a fundamental part of modern healthcare. Pharma brands that embrace direct-to-patient engagement gain a competitive edge: building stronger connections, improving patient outcomes, and driving long-term brand loyalty.

60% of consumers would pay more for virtual primary care over in-person visits.

52% of clinicians believe they deliver more effective treatment and follow-ups via teleconsultations.

55% of people say they receive better care via teleconsultations.

How virtual care turns brand awareness into action

Pharma companies are investing in commercialization, but reaching patients at the right moment remains a challenge. Virtual care bridges the gap, connecting brands directly to consumers and turning awareness into action.

See how Wheel enables seamless patient engagement—allowing consumers to go from seeing an ad to speaking with a provider in moments.

Virtual care is more than a prescription

Reduce risks and improve treatment effectiveness

Clinician oversight enhances long-term health by preventing adverse effects, addressing underlying conditions, and optimizing treatment plans with real-time patient monitoring.

Keep patients engaged and adherent

Regular check-ins and clinician support provide ongoing guidance. Education on medication, side effects, and lifestyle changes can increase confidence and long-term adherence.

Deliver whole-person care

Virtual care integrates mental health, lifestyle, and social factors into personalized care plans, leading to better patient outcomes and a stronger provider-patient connection.

Virtual care connects pharma to consumers

Support clinical trials with better patient retention

Virtual care expands patient recruitment and retention by removing barriers to care. Remote monitoring and clinician-led follow-ups may improve adherence and ensure stronger clinical outcomes.

Launch and commercialize products more effectively

Integrating virtual care into patient journeys accelerates commercialization by building brand awareness and driving faster adoption. By enabling quicker treatment initiation, pharma brands can maximize lifetime value and expand market impact.

Compete with new market entrants by building brand loyalty

Beyond prescriptions, virtual care strengthens patient relationships and helps defend against generics. Continuous engagement positions your company as a long-term health partner, increasing lifetime value and reinforcing brand trust.

How pharma can build brand and above-brand virtual care strategies

Pharma brands engage patients in two ways: through brand-specific strategies that focus on individual therapies and above-brand strategies that scale across portfolios and disease states.

1

Brand: Increase product adoption and adherence

Virtual care removes barriers to access, helping patients start and stay on therapy. By integrating telehealth into patient journeys, brands can motivate adherence, enhance education, and strengthen engagement.

2

Above-brand: Expand patient access across therapeutic areas

Patients seek complete care, not just individual prescriptions. An above-brand strategy leverages virtual care across multiple brands in a therapeutic category, positioning your company as a trusted leader in managing complex conditions.

3

Above-brand: Build long-term patient relationships

Beyond a single treatment, virtual care enables scalable, cross-portfolio engagement. By embedding telehealth solutions across multiple brands and disease states, pharma companies can improve retention, strengthen loyalty, and reinforce their role as long-term health partners.

How Wheel and Huma are advancing telehealth for pharma

Wheel and Huma are partnering to bring pharma brands closer to patients by combining telehealth infrastructure with cutting-edge digital health solutions. With Huma’s expertise in remote patient monitoring, digital biomarkers, and AI-driven insights, pharma companies can enhance patient engagement, improve treatment adherence, and optimize clinical outcomes.

Together, Wheel and Huma offer scalable, regulatory-compliant solutions that integrate remote monitoring, virtual consultations, and real-time patient data into commercialization strategies. This partnership enables life sciences companies to create continuous, personalized care experiences that improve outcomes and drive long-term patient engagement.

Image of multiple screenshots featuring the patient experience using Wheel's Horizon platform

Take the next step with virtual care and direct-to-patient engagement

Pharma has traditionally focused on education and prescription access, but today’s patients expect more. They want direct, continuous engagement that supports their health journey at every stage.

Marketing alone isn’t enough. Virtual care moves patients from awareness to action, building trust, improving adherence, and driving better outcomes. Brands that act now won’t just meet patient expectations—they’ll lead the future of pharma engagement.

6+ million
Patient visits
> 95%
On-time response rate 24/7/365
<2 mins
Avg async response time
24/7/365
Patient availability

Connect with Wheel

Let’s create a virtual care strategy that connects your brand directly to patients.

Schedule a consultation and start your virtual care strategy today.

🗞️ Huma and Wheel Partner To Deliver a Direct-to-Consumer Platform as a Service  Learn more →

×